Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple blood draw may spot kidney cancer early

NCT ID NCT04113486

Recruiting now Diagnosis Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study is testing whether a protein called NMAP, measured in a blood sample, can help tell apart people with newly diagnosed kidney cancer from those without cancer. Researchers will compare NMAP levels in about 400 adults — half with kidney cancer and half without — to see how accurately the protein signals the disease. If NMAP proves reliable, it might one day become a simple, non-invasive tool for catching kidney cancer earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
blood test measuring NMAP protein levels
What this could lead to
If NMAP levels reliably distinguish kidney cancer from non-cancer, this could lead to a simple blood test for earlier detection.
What could go wrong
This is an early observational study, not a treatment trial. NMAP may not prove accurate enough for routine screening, and results need validation in larger, diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA, RENAL CELL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

kidney cancer renal cell adenocarcinoma renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA, RENAL CELL

Contacts and locations

Locations

  • Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine

    RECRUITING

    Shanghai, Shanghai Municipality, 200092, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.